Free Trial

Prime Medicine (PRME) Institutional Ownership

→ His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad)
Free PRME Stock Alerts
$4.42
+0.12 (+2.79%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media

Institutional Ownership Changes (13F Filings) for Prime Medicine (NYSE:PRME)

Current
Institutional Ownership
Percentage
70.37%
Number of
Institutional Buyers
(last 12 months)
29
Total
Institutional Inflows
(last 12 months)
$70.33M
Number of
Institutional Sellers
(last 12 months)
10
Total
Institutional Outflows
(last 12 months)
$32.77M
Get PRME Insider Trade Alerts

Want to know when executives and insiders are buying or selling Prime Medicine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

PRME Institutional Buying and Selling by Quarter

Prime Medicine Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/19/2024 Sumitomo Mitsui Trust Holdings Inc.3,364,663$23.55M0.0%-4.4%2.805%
4/15/2024 TrueMark Investments LLC85,183$596K0.5%+13.5%0.071%
4/10/2024 Green Alpha Advisors LLC33,738$236K0.2%+14.2%0.028%
2/21/2024Chelsea Counsel Co.5,000$44K0.0%+733.3%0.005%
2/14/2024Vestal Point Capital LP20,306$180K0.0%N/A0.021%
2/13/2024Bollard Group LLC361,136$3.20M0.1%N/A0.371%
2/9/2024Trexquant Investment LP26,983$239K0.0%N/A0.028%
2/8/2024Nikko Asset Management Americas Inc.3,519,029$31.18M0.3%-3.2%3.616%
2/6/2024Vestmark Advisory Solutions Inc.144,288$1.28M0.1%N/A0.148%
2/6/2024Levin Capital Strategies L.P.20,000$177K0.0%N/A0.021%
2/1/2024New York State Common Retirement Fund8,440$75K0.0%-48.3%0.009%
2/1/2024Greenwich Wealth Management LLC513,001$4.55M0.4%+16.9%0.527%
1/30/2024Strs Ohio17,100$151K0.0%N/A0.018%
1/30/2024 Sumitomo Mitsui Trust Holdings Inc.3,519,029$31.18M0.0%-3.2%3.616%
1/24/2024Mirae Asset Global Investments Co. Ltd.21,301$189K0.0%-7.5%0.022%
1/24/2024China Universal Asset Management Co. Ltd.11,258$100K0.0%N/A0.012%
1/17/2024 ARK Investment Management LLC3,138,270$27.81M0.2%+19.7%3.225%
1/12/2024SG Americas Securities LLC10,128$90K0.0%N/A0.010%
1/11/2024 TrueMark Investments LLC75,030$665K0.7%N/A0.077%
1/5/2024 Green Alpha Advisors LLC29,538$262K0.2%-21.9%0.030%
12/18/2023Vanguard Group Inc.3,951,793$37.70M0.0%+18.5%4.060%
12/6/2023Citigroup Inc.56,193$536K0.0%+296.8%0.058%
11/14/2023Profund Advisors LLC21,995$210K0.0%N/A0.023%
11/13/2023FMR LLC3,922,416$37.42M0.0%-2.9%4.030%
11/13/2023Rafferty Asset Management LLC128,876$1.23M0.0%N/A0.132%
11/9/2023Citigroup Inc.56,193$536K0.0%+296.8%0.058%
11/8/2023Oppenheimer & Co. Inc.21,537$205K0.0%+40.0%0.022%
11/7/2023Barclays PLC65,140$621K0.0%+726.8%0.067%
11/7/2023Greenwich Wealth Management LLC439,021$4.19M0.4%+111.1%0.451%
10/30/2023 Sumitomo Mitsui Trust Holdings Inc.3,634,848$34.68M0.0%+18.6%3.736%
10/27/2023 Allspring Global Investments Holdings LLC3,067$29K0.0%-73.2%0.003%
10/27/2023TD Asset Management Inc104,542$997K0.0%+55.9%0.107%
10/26/2023Mirae Asset Global Investments Co. Ltd.23,016$220K0.0%+22.0%0.024%
10/24/2023Bank of New York Mellon Corp115,389$1.10M0.0%+11.8%0.119%
10/18/2023 ARK Investment Management LLC2,622,429$25.02M0.2%+7.1%2.695%
10/10/2023 Green Alpha Advisors LLC37,815$361K0.3%+205.3%0.039%
9/21/2023Barclays PLC7,879$116K0.0%+47.7%0.008%
8/14/2023Casdin Capital LLC367,175$5.38M0.5%-50.0%0.377%
8/11/2023Penserra Capital Management LLC8,107$118K0.0%+15.8%0.008%
8/10/2023Metropolitan Life Insurance Co NY2,203$32K0.0%+206.8%0.002%
His win rate puts Warren Buffett to shame… (Ad)

Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.

Click here now for the full story.
8/9/2023TD Asset Management Inc67,071$983K0.0%+180.4%0.069%
8/7/2023Principal Financial Group Inc.18,029$264K0.0%N/A0.019%
8/7/2023Brown Brothers Harriman & Co.10,065$147K0.0%N/A0.010%
8/4/2023American International Group Inc.19,040$279K0.0%+274.3%0.020%
8/4/2023Alphabet Inc.11,862,498$173.79M9.3%-10.7%12.200%
7/31/2023Levin Capital Strategies L.P.20,000$293K0.0%N/A0.021%
7/31/2023Greenwich Wealth Management LLC208,000$3.05M0.3%-40.4%0.214%
7/31/2023 Sumitomo Mitsui Trust Holdings Inc.3,063,751$44.88M0.0%+207.1%3.151%
7/24/2023 Allspring Global Investments Holdings LLC11,441$168K0.0%+894.0%0.012%
7/18/2023 Allspring Global Investments Holdings LLC11,441$168K0.0%+894.0%0.012%
7/10/2023 ARK Investment Management LLC2,449,199$35.88M0.2%+27.4%2.519%
7/6/2023 Green Alpha Advisors LLC12,386$181K0.1%N/A0.013%
(Data available from 1/1/2016 forward)

PRME Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PRME shares?

During the previous two years, 34 institutional investors and hedge funds held shares of Prime Medicine. The most heavily invested institutionals were Alphabet Inc. ($173.79M), Vanguard Group Inc. ($37.70M), FMR LLC ($37.42M), Nikko Asset Management Americas Inc. ($31.18M), ARK Investment Management LLC ($27.81M), Sumitomo Mitsui Trust Holdings Inc. ($23.55M), and Casdin Capital LLC ($5.38M).Learn more on PRME's institutional investors.

What percentage of Prime Medicine stock is owned by institutional investors?

70.37% of Prime Medicine stock is owned by institutional investors. Learn more on PRME's institutional investor holdings.

Which institutional investors have been buying Prime Medicine stock?

Of the 29 institutional investors that purchased Prime Medicine stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Sumitomo Mitsui Trust Holdings Inc. ($2.64M), ARK Investment Management LLC ($1.22M), Vanguard Group Inc. ($617.31K), Bollard Group LLC ($361.14K), Greenwich Wealth Management LLC ($305.00K), Vestmark Advisory Solutions Inc. ($144.29K), and Rafferty Asset Management LLC ($128.88K).

How much institutional buying is happening at Prime Medicine?

Institutional investors have bought a total of 6,001,428 shares in the last 24 months. This purchase volume represents approximately $70.33M in transactions.

Which Prime Medicine major shareholders have been selling company stock?

Of the 10 institutional investors that sold Prime Medicine stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Alphabet Inc. ($1.42M), Casdin Capital LLC ($367.18K), Sumitomo Mitsui Trust Holdings Inc. ($270.19K), Greenwich Wealth Management LLC ($141K), FMR LLC ($116.80K), Nikko Asset Management Americas Inc. ($115.82K), and Allspring Global Investments Holdings LLC ($8.37K).

How much institutional selling is happening at Prime Medicine?

Institutional investors have sold a total of 2,459,414 shares in the last 24 months. This volume of shares sold represents approximately $32.77M in transactions.


Related Companies:
This page (NYSE:PRME) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
His win rate puts Warren Buffett to shame…
Investing Daily
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
Biden out June 13; Kamala won’t replace him?
Paradigm Press
The World's First "$20 Trillion Drug?"
Behind the Markets